Interleukin-12 Requires Initial CD80-mediated T-Cell Activation to Support Immune Responses Toward Human Breast and Ovarian Carcinoma
Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700050
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 1999
Authors
Publisher
Springer Science and Business Media LLC